Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19.
Clin Immunol
; 226: 108716, 2021 05.
Article
in English
| MEDLINE | ID: covidwho-1152310
ABSTRACT
Lung inflammation and damage is prominent in people infected with SARS-Cov-2 and a major determinant of morbidity and mortality. We report the deposition of complement components in the lungs of people who succumbed to COVID-19 consistent with the activation of the classical and the alternative pathways. Our study provides strong rationale for the expansion of trials involving the use of complement inhibitors to treat patients with COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Complement Activation
/
Complement Pathway, Alternative
/
Lung Injury
/
COVID-19
Type of study:
Case report
Topics:
Long Covid
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Clin Immunol
Journal subject:
Allergy and Immunology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS